138 related articles for article (PubMed ID: 38357130)
1. Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals.
Samaila A; Biambo AA; Usman N; Aliyu UM; Abdullahi A; Adibe MO
Afr Health Sci; 2023 Sep; 23(3):261-268. PubMed ID: 38357130
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.
Amo-Antwi K; Agambire R; Konney TO; Nguah SB; Dassah ET; Nartey Y; Appiah-Kubi A; Tawiah A; Tannor EK; Peprah A; Ansah MB; Sam D; Akakpo PK; Ankobea F; Djokoto RM; Idun MYK; Opare-Addo HS; Opoku BK; Odoi AT; Johnston C
PLoS One; 2022; 17(6):e0268831. PubMed ID: 35657957
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
Bakari F; Abdul MA; Ahmed SA
Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
5. A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors.
Dahl AA; Bentzen AG; Fosså SD; Hess SL; Kiserud CE
Acta Obstet Gynecol Scand; 2023 Feb; 102(2):218-225. PubMed ID: 36683549
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neoadjuvant treatments followed by radical surgery or chemoradiation on quality of life in patients with stage IB2-IIA cervical cancer.
Sun Z; Huang B; Liu C; Yang Y; Rao Y; Du Y; Ma Y
Gynecol Oncol; 2020 May; 157(2):536-541. PubMed ID: 32173046
[TBL] [Abstract][Full Text] [Related]
7. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of colorectal cancer in a resource-limited setting: Ahmadu Bello university teaching hospital, Zaria, Nigeria.
Theyra-Enias H; Tumba N; Popoola OB
Niger J Clin Pract; 2022 Jun; 25(6):923-930. PubMed ID: 35708435
[TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
10. Pattern of oncologic emergencies seen in adult cancer patients attending the Radiotherapy and Oncology Centre, Ahmadu Bello University Teaching Hospital, Zaria - Nigeria.
Adewuyi SA; Ajekigbe AT; Campbell OB; Mbibu NH; Oguntayo AO; Kolawole AO; Usman A; Samaila MO; Shehu SM
Niger Postgrad Med J; 2012 Dec; 19(4):208-14. PubMed ID: 23385675
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of complementary and alternative medicine use among cancer patients in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria.
Aliyu UM; Awosan KJ; Oche MO; Taiwo AO; Jimoh AO; Okuofo EC
Niger J Clin Pract; 2017 Dec; 20(12):1576-1583. PubMed ID: 29378990
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and practice of cervical screening among female health workers in Sokoto, North Western Nigeria.
Nwobodo EI; Malami SA
Niger Postgrad Med J; 2005 Dec; 12(4):255-7. PubMed ID: 16380734
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in women of reproductive age: a comparative study of infertile and fertile women in a Nigerian tertiary centre.
Aduloju OP; Olaogun OD; Aduloju T
J Obstet Gynaecol; 2018 Feb; 38(2):247-251. PubMed ID: 28920515
[TBL] [Abstract][Full Text] [Related]
14. Social support buffers the effect of self-esteem on quality of life of early-stage cervical cancer survivors in Taiwan.
Li CC; Chen ML; Chang TC; Chou HH; Chen MY
Eur J Oncol Nurs; 2015 Oct; 19(5):486-94. PubMed ID: 25782718
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting quality of life of cervical cancer patients: A multivariate analysis.
Singh U; Verma ML; Rahman Z; Qureshi S; Srivastava K
J Cancer Res Ther; 2019; 15(6):1338-1344. PubMed ID: 31898670
[TBL] [Abstract][Full Text] [Related]
16. Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire.
Samaila A; Isah A; Biambo AA; Usman N; Aliyu UM; Abdullahi A; Adibe MO
J Oncol Pharm Pract; 2022 Jul; ():10781552221112159. PubMed ID: 35790452
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancer.
Scheepers ERM; Vink GR; Schiphorst AHW; Emmelot-Vonk MH; van Huis-Tanja LH; Hamakerl ME
Eur Geriatr Med; 2023 Jun; 14(3):565-572. PubMed ID: 36964869
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital.
Ramasubbu SK; Pasricha RK; Nath UK; Rawat VS; Das B
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1312. PubMed ID: 33295136
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Monk BJ; Tewari KS; Dubot C; Caceres MV; Hasegawa K; Shapira-Frommer R; Salman P; Yañez E; Gümüş M; Hurtado de Mendoza MO; Samouëlian V; Castonguay V; Arkhipov A; Tekin C; Li K; Martin Nguyen A; Monberg MJ; Colombo N; Lorusso D
Lancet Oncol; 2023 Apr; 24(4):392-402. PubMed ID: 36878237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
